MARKETS
KeyVex News: Markets
Market news from the public record. Every figure in every story is checked against the filing it cites, and linked to it.
MarketsNovogratz entities sold at $18.10, $36. One paid about $13Read More
MarketsWendy's rejects Peltz's $7.35 bid and caps his group's stakeRead More
MarketsLiberty Global insiders sold $4.7M. Then its CEO boughtRead More
MarketsTrump Media may not be able to pay if lenders cash outRead More
MarketsFIS's profit-per-share outlook: 8% to 10%, now about 2%Read More
MarketsCVS plans a breakup. It trailed an S&P 500 fund since AetnaRead More
MarketsIntel CEO's trust paid $95, then $64.73 after the fallRead More
MarketsBerkshire's smallest, highest-priced round of Sirius buyingRead More
MarketsMGM's buybacks can lift Diller's company past its capRead More
MarketsBloomin' eased a franchisee's fees for years. Now it bidsRead More
MarketsHenry Schein's raised forecast counts its tariff refundRead More
Markets$5 million to Icahn's firm for a pledge CVR's sale would endRead More
MarketsRollins family firm sold $3.1B of stock, then bought $50MRead More
MarketsSix quarters of fewer vet visits, six of growing test salesRead More
MarketsPrecigen's only approved drug got a rival from InovioRead More
MarketsMarvell's $1,132 Lumentum price: $883.80 in stock by signingRead More
MarketsAfter three down quarters, Coinbase's crypto rose $715.0MRead More
MarketsExxon sold 1% more fuel. Refining profit nearly quadrupledRead More
MarketsPaid in stock for Sinclair Oil, HF Sinclair bought most backRead More
MarketsIntel CEO's family trust paid $95; shares traded near $64Read More
MarketsInstacart traded about $8 under DoorDash's $65 priceRead More
MarketsMSC's chairman bought about $29 million after a 15% fallRead More
MarketsLilly says its drug beat Ozempic's weight loss 20.9% to 9.4%Read More
MarketsAccenture CEO's first market buy in her filings: $3 millionRead More 